Related Experiment Video
Updated: Sep 9, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Design and synthesis of fluorescent probe for determination of β-glucosidase activity and inhibitor screening
Xiaoyan Huang1, Yujie Niu1, Chao Wei1
1Key Laboratory of Chemical Biology of Hebei Province, College of Chemistry and Material Science, Hebei University, Baoding, Hebei 071002, PR China.
Abstract:
β-Glucosidase (β-Glc) is widely expressed across various organisms and plays essential roles in physiological processes. Notably, β-Glc serves as a diagnostic marker for certain diseases and represents a potential therapeutic target. Developing tools for detecting β-Glc activity and discovering novel β-Glc inhibitors holds significant potential. In this study, we designed and synthesized a novel fluorescent probe named P1, utilizing resorufin as the fluorophore. This probe demonstrates exceptional selectivity, sensitivity (LOD = 8.2 × 10-5 U/mL), and affinity (Km = 7.59 μmol/L) towards β-Glc. It enables efficient imageing of β-Glc in living cells and has been successfully applied for screening inhibitors. Using this probe, a novel tricyclic benzimidazole azasugar inhibitor for β-Glc was identified. Overrall, the developed probe represents a powerful tool for β-Glc activity detection and inhibitor screening.

